RNTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Rein Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.55−0.04 (-6.49%)
Close on Oct 19, 2026
- Market cap
- $37.03M
- P/E (TTM)
- –
- Dividend yield
- 0.00%
Fundamental chart
Pick a measure to chart its full history
$0FY2025